Stockreport

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers [Financial Post (Toronto, Ontario, Canada)]

Zymeworks Inc.  (ZYME) 
Last zymeworks inc. earnings: 3/2 04:15 pm Check Earnings Report
US:NYSE Investor Relations: ir.zymeworks.com/overview
PDF Author of the article: You can save this article by registering for free here . Or sign-in if you have an account. VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE [Read more]